Cargando…

Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria

BACKGROUND: Public health emergencies raise significant concerns about corruption and accountability; however, these concerns can manifest in different ways across diverse locations. For instance, more developed countries with a stronger rule of law may experience more corruption in vaccine procurem...

Descripción completa

Detalles Bibliográficos
Autores principales: Onwujekwe, Obinna, Orjiakor, Charles, Ogbozor, Pamela, Agu, Ifunanya, Agwu, Prince, Wright, Tom, Balabanova, Dina, Kohler, Jillian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641993/
https://www.ncbi.nlm.nih.gov/pubmed/37957711
http://dx.doi.org/10.1186/s40545-023-00649-7
_version_ 1785146869550153728
author Onwujekwe, Obinna
Orjiakor, Charles
Ogbozor, Pamela
Agu, Ifunanya
Agwu, Prince
Wright, Tom
Balabanova, Dina
Kohler, Jillian
author_facet Onwujekwe, Obinna
Orjiakor, Charles
Ogbozor, Pamela
Agu, Ifunanya
Agwu, Prince
Wright, Tom
Balabanova, Dina
Kohler, Jillian
author_sort Onwujekwe, Obinna
collection PubMed
description BACKGROUND: Public health emergencies raise significant concerns about corruption and accountability; however, these concerns can manifest in different ways across diverse locations. For instance, more developed countries with a stronger rule of law may experience more corruption in vaccine procurement, whereas developing countries may experience more corruption at the point of distribution and delivery to end users. This research focuses on corruption concerns in Nigeria, specifically examining the procurement and distribution of COVID-19 vaccines. METHODS: This paper utilizes a scoping review and a qualitative research approach. Key informants (n = 40) involved in the procurement and distribution of COVID-19 vaccines across two states in Nigeria were interviewed. Findings from the scoping review were summarized, and collected data were inductively coded and analysed in themes, revealing clear examples of implementation irregularities and corruption in the country’s COVID-19 vaccination processes. RESULTS: Vaccination programme budgeting processes were unclear, and payment irregularities were frequently observed, resulting in vaccinators soliciting informal payments while in the field. Recruitment and engagement of vaccination personnel was opaque, while target vaccination rates incentivized data falsification during periods of vaccine hesitancy. Accountability mechanisms, such as health worker supervision, vaccination data review, and additional technical support provided by donors were implemented but not effective at preventing corruption among frontline workers. CONCLUSIONS: Future accountability measures should be evidence-driven based on findings from this research. Personnel recruitment, contracting, budgeting, and remuneration should focus on transparency and accountability.
format Online
Article
Text
id pubmed-10641993
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-106419932023-11-14 Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria Onwujekwe, Obinna Orjiakor, Charles Ogbozor, Pamela Agu, Ifunanya Agwu, Prince Wright, Tom Balabanova, Dina Kohler, Jillian J Pharm Policy Pract Research BACKGROUND: Public health emergencies raise significant concerns about corruption and accountability; however, these concerns can manifest in different ways across diverse locations. For instance, more developed countries with a stronger rule of law may experience more corruption in vaccine procurement, whereas developing countries may experience more corruption at the point of distribution and delivery to end users. This research focuses on corruption concerns in Nigeria, specifically examining the procurement and distribution of COVID-19 vaccines. METHODS: This paper utilizes a scoping review and a qualitative research approach. Key informants (n = 40) involved in the procurement and distribution of COVID-19 vaccines across two states in Nigeria were interviewed. Findings from the scoping review were summarized, and collected data were inductively coded and analysed in themes, revealing clear examples of implementation irregularities and corruption in the country’s COVID-19 vaccination processes. RESULTS: Vaccination programme budgeting processes were unclear, and payment irregularities were frequently observed, resulting in vaccinators soliciting informal payments while in the field. Recruitment and engagement of vaccination personnel was opaque, while target vaccination rates incentivized data falsification during periods of vaccine hesitancy. Accountability mechanisms, such as health worker supervision, vaccination data review, and additional technical support provided by donors were implemented but not effective at preventing corruption among frontline workers. CONCLUSIONS: Future accountability measures should be evidence-driven based on findings from this research. Personnel recruitment, contracting, budgeting, and remuneration should focus on transparency and accountability. BioMed Central 2023-11-13 /pmc/articles/PMC10641993/ /pubmed/37957711 http://dx.doi.org/10.1186/s40545-023-00649-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Onwujekwe, Obinna
Orjiakor, Charles
Ogbozor, Pamela
Agu, Ifunanya
Agwu, Prince
Wright, Tom
Balabanova, Dina
Kohler, Jillian
Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria
title Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria
title_full Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria
title_fullStr Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria
title_full_unstemmed Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria
title_short Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria
title_sort examining corruption risks in the procurement and distribution of covid-19 vaccines in select states in nigeria
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641993/
https://www.ncbi.nlm.nih.gov/pubmed/37957711
http://dx.doi.org/10.1186/s40545-023-00649-7
work_keys_str_mv AT onwujekweobinna examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT orjiakorcharles examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT ogbozorpamela examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT aguifunanya examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT agwuprince examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT wrighttom examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT balabanovadina examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria
AT kohlerjillian examiningcorruptionrisksintheprocurementanddistributionofcovid19vaccinesinselectstatesinnigeria